Home/Filings/4/0001847903-25-000074
4//SEC Filing

GOYAL ARJUN 4

Accession 0001847903-25-000074

CIK 0001847903other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 5:49 PM ET

Size

8.2 KB

Accession

0001847903-25-000074

Insider Transaction Report

Form 4
Period: 2025-05-15
GOYAL ARJUN
Director
Transactions
  • Purchase

    Ordinary Shares

    2025-05-15$12.24/sh+44,939$550,23844,939 total(indirect: See footnote)
  • Purchase

    Ordinary Shares

    2025-05-16$12.73/sh+417,646$5,315,005462,585 total(indirect: See footnote)
Footnotes (4)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.99 to $12.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  • [F3]Shares held by Vinyanshu Ventures LLC, an entity controlled by the Reporting Person. The Reporting Person disclaims beneficial ownership of the shares reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16"), except to the extent of his pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of any of the reported shares for purposes of Section 16 or any other purpose.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.45 to $13.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Issuer

Centessa Pharmaceuticals plc

CIK 0001847903

Entity typeother

Related Parties

1
  • filerCIK 0001861844

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 5:49 PM ET
Size
8.2 KB